Biomics Biopharma
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A Chinese gene and cell therapy company focused on oncology and genetic diseases using viral vectors and gene editing.
OncologyGene TherapyCell Therapy
Technology Platform
An integrated platform for gene therapy (viral vectors) and cell therapy (including gene-edited cells) development.
Opportunities
Addressing large unmet needs in oncology and genetic diseases with potentially curative, one-time treatment modalities.
Risk Factors
Faces substantial technical, manufacturing, and safety hurdles inherent to gene and cell therapies, alongside uncertain reimbursement pathways.
Competitive Landscape
Enters a high-stakes race with numerous well-funded global and Chinese companies developing similar gene and cell therapies.